
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.
Doesn’t follow this closely. Canadian operations appear to be excellent and well run and have a strong position in the market. Looking at lifecos in general, in the current environment where it is very difficult to get investors deposits in SEG funds, it is the change in interest rates that is really going to impact earnings growth. If interest rates go up, then lifecos benefit because the present value of liabilities is reduced. It also has exposure to Asia, so you have to make a call on this factor.
Sun Life (SLF-T) or Manulife (MFC-T)? In a slowly rising interest rate environment, both banks and lifecos will benefit, and you want to have representation in both groups. She owns 3 banks and 1 lifeco. Both have done well. This one was lagging, but has now played a bit of catch-up. Both just reported good results. Her preference would be this because she likes their Asian exposure, which will be a faster growth market.
Sell bank stocks and put it into Manulife?She likes Manulife, because she feels the new management team will be more aggressive in selling off some of the assets that are not a good fit or are not growing as fast. Her feeling is that they will sell assets as opposed to selling off the whole John Hancock company. They are doing really, really well in Asia. A unique way of playing Asia. This is probably going to be her biggest weighting after they report. The growth of Manulife could possibly be better than the banks.
A great long term compounder but short term it is outperforming in Asia-pacific. That is caused by a desire for nationals to get money out of the country so he is suspicious of the growth going forward. It is It is a long term opportunity but he is not bullish short term. It is doing a great job in Canada and the US looks to be on track.
Had a pretty nice run some months ago. His concern is that there is too much emphasis on building their far east, particularly their China business. Financial institutions going into China are subject to a situation where their business could disappear overnight if the Chinese government decided to step in. He would rather go with Sun Life (SLF-T).
He can’t comment on the day to day performance and possible short selling. They have a very significant presence in fast growing Asia. He has nothing negative to say about them. They suffered from complicated accounting. If you think interest rates will go up over time then they will benefit. You should not worry too much about day to day volatility.
Everything is going well with all their businesses. They will definitely be a beneficiary of rising rates on both sides of the border. The US business is doing really, really well. Their Asian business is doing really, really well. A great Canadian business that is a global company. Dividend yield of 3.2%. (Analysts’ price target is $28.)
(A Top Pick Oct 28/16. Up 39%.) Had a really good pop, but it isn’t going to repeat that. He still it likes it. It has Asia growth and is a beneficiary of higher rates, which is primarily why it has gone up. Earnings are growing. Expects they will raise the dividend a little in Jan or Feb. A new management team came in recently which impressed the street in their initial meeting.
MFC-T vs. SLF-T. It is a close call. He would have to go with MFC-T because he believes they have more recovery upside. MFC-T has some issues but if they address them they will have more upside.